Achim Aigner
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Circular RNAs in diseases
- Fibroblast Growth Factor Research
Papers in
-
- RNA Interference and Gene Delivery 82
- Advanced biosensing and bioanalysis techniques 53
- Fibroblast Growth Factor Research 12
-
- MicroRNA in disease regulation 28
- Co-authors
- Frank Czubayko (36 shared papers)Sabrina Höbel (24 shared papers)Anton Wellstein (13 shared papers)Maik Friedrich (2 shared papers)Anastasia Malek (9 shared papers)Udo Bakowsky (10 shared papers)Thomas Kissel (7 shared papers)Alexander Ewe (34 shared papers)
- Journals
- Cancers (8 papers)European Journal of Pharmaceutics and Biopharmaceutics (8 papers)Pharmaceutics (7 papers)Neoplasia (6 papers)Oncogene (5 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Achim Aigner
202 papers receiving 9.5k citations
Achim Aigner's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 1.9k
- Molecular Biology 6.6k
- Biomaterials 1.1k
- Cell Biology 700
- Oncology 976
Countries citing papers authored by Achim Aigner
This map shows the geographic impact of Achim Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Aigner more than expected).
Fields of papers citing papers by Achim Aigner
This network shows the impact of papers produced by Achim Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Aigner. The network helps show where Achim Aigner may publish in the future.
Co-authors
The 25 scholars most cited alongside Achim Aigner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Hit paper breakdown → | 2004 | 597 |
| 2 | 2011 | 346 | |
| 3 | 2001 | 318 | |
| 4 | 2005 | 300 | |
| 5 | Therapeutic siRNA: State-of-the-Art and Future Perspectives Hit paper breakdown → | 2022 | 277 |
| 6 | 2006 | 247 | |
| 7 | 1997 | 212 | |
| 8 | 2006 | 195 | |
| 9 | 2013 | 186 | |
| 10 | 2010 | 175 | |
| 11 | 2006 | 165 | |
| 12 | 2009 | 164 | |
| 13 | 2010 | 156 | |
| 14 | 2014 | 150 | |
| 15 | 2002 | 150 | |
| 16 | 2021 | 140 | |
| 17 | 2017 | 136 | |
| 18 | 2008 | 132 | |
| 19 | 2007 | 132 | |
| 20 | 2001 | 129 |
About Achim Aigner
Achim Aigner is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Biomaterials, having authored 208 papers that have together received 9.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (82 papers), Advanced biosensing and bioanalysis techniques (53 papers), MicroRNA in disease regulation (28 papers), Proteoglycans and glycosaminoglycans research (15 papers), Virus-based gene therapy research (15 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Fibroblast Growth Factor Research (12 papers) and Cancer Mechanisms and Therapy (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (6.6k citations), Biomaterials (1.1k citations), Cell Biology (700 citations) and Oncology (976 citations). Achim Aigner has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Frank Czubayko, Sabrina Höbel, Anton Wellstein, Maik Friedrich, Anastasia Malek, Udo Bakowsky, Thomas Kissel, Alexander Ewe, Ulrike Weirauch and Roland K. Hartmann. Their work appears in journals such as Cancers, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutics, Neoplasia and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.